IP Library › Assignment 033124/0053
Patent Assignment
Reel/Frame 033124/0053

Assignment of Undivided 50% of Assignor's Interest

Recorded: 2014-06-10 Pages: 4
Assignor
MEDAREX, INC.
Executed: 2007-12-27
Assignee
ONO PHARMACEUTICAL CO., LTD.
1-5, DOSHOMACHI 2-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, 541-8526, JAPAN
Covered Properties (5)
Monoclonal Antibodies to Programmed Death 1 (Pd-1)
Patent: 8,779,105 →
Application: 13/210,137 →
Publication: US 2013/0133091
Methods for Treating Cancer Using Anti-Pd-1 Antibodies in Combination with Anti-Ctla-4 Antibodies
Patent: 9,358,289 →
Application: 14/227,733 →
Publication: US 2014/0212422
Monoclonal Antibodies to Programmed Death 1 (Pd-1)
Patent: 9,387,247 →
Application: 14/244,405 →
Publication: US 2014/0294852
Monoclonal Antibodies to Programmed Death 1 (Pd-1)
Patent: 9,492,539 →
Application: 14/248,462 →
Publication: US 2014/0348743
Methods for Treating Cancer Using Anti-Pd-1 Antibodies
Patent: 9,492,540 →
Application: 14/270,750 →
Publication: US 2014/0328833
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger Jun 13, 2013
From: MEDAREX, INC.
To: MEDAREX, L.L.C.
Reel/Frame 030603/0924 →
Assignment of Assignor's Interest Jun 10, 2014
From: KORMAN, ALAN J.; SRINIVASAN, MOHAN; WANG, CHANGYU; SELBY, MARK J.
To: MEDAREX, INC.
Reel/Frame 033069/0061 →
Assignment of Assignor's Interest Jun 10, 2014
From: HUANG, HAICHUN
To: MEDAREX, INC.
Reel/Frame 033069/0339 →
Merger Jun 11, 2014
From: MEDAREX, INC.
To: MEDAREX, L.L.C.
Reel/Frame 033080/0678 →
Merger Nov 7, 2014
From: MEDAREX, L.L.C.
To: E. R. SQUIBB & SONS, L.L.C.
Reel/Frame 034126/0342 →
Corrective Assignment to Correct the Incorrect Spelling of Inventor "Bing Chen" to "Bingliang Chen" Previously Recorded on Reel 033069 Frame 0061. Assignor(S) Hereby Confirms the Correct Spelling of Inventor as "Bingliang Chen". Feb 4, 2015
From: KORMAN, ALAN J.; SRINIVASAN, MOHAN; WANG, CHANGYU; SELBY, MARK J.
To: MEDAREX, INC.
Reel/Frame 034905/0592 →